Visit Your Local PBS Station PBS Home PBS Home Programs A-Z TV Schedules Watch Video Support PBS Shop PBS Search PBS
On Air

Paul Kangas' Stocks In The News

Get RSS feed.
Print Story Email Story

Paul Kangas' Stocks in the News

Wednesday, December 05, 2007
Picture of NBR Anchor & Financial Commentator Paul Kangas

JEFF YASTINE: New economic data helped drive the stock markets higher today, right from the start. By the midpoint of the session, the Dow was up almost 200 points. Buyers welcomed a Commerce Department report showing unexpected gains in factory orders and adding to the enthusiasm, a private report by ADP predicting a 189,000 job jump in November's employment numbers. So, the Dow closed up 196.23 at 13,444.96. And the NASDAQ jumping 46.53 to 2,666.36 and the S&P 500 adding 22.22 to 1,485 and a fraction and in the bond market, the 10-year note falling 16/32 to 102 11/32 and the yield at 3.96 percent.

Citigroup (C) topping our list again, gaining $1.14, but an analyst at CIBC World Markets cut earnings targets three years out on Citi in the belief that mortgage losses of up to $6.5 billion next year because of its huge exposure to high-risk mortgages.

Pfizer (PFE) gaining $0.51. The Dow component in a pact with Avalor (ph) to develop compounds for new pain relievers. That should add to Pfizer's portfolio of pain treatments.

General Electric (GE) gaining $0.46.

Advanced Micro (AMD) losing $0.34. There's a bug in AMD's new Barcelona chips, but a spokesman at the company says there's a software patch to fix the problem. Order (ph) shipments not affected we're told.

Ford Motor Co (F) gaining just a penny.

And then Bank of America (BAC) gaining $1.16.

EMC Corp (EMC) up a quarter.

JPMorgan Chase (JPM) advancing $0.75.

Time Warner (TWX) losing a fraction.

Countrywide Financial (CFC) up $0.42.

American Intl Group (AIG) jumping $2.50. CEO Martin Sullivan says the firm is well-diversified to offset exposure to the troubled housing market.

And then Genentech (DNA) sank $6.65 after being halted this afternoon. An FDA panel says there's insufficient data on using the company's colon cancer drug Avastin as a new treatment for breast cancer.

MBIA (MBI) collapsing more than $5. Moody's says it may cut MBIA's AAA rating because of the bond insurer's deteriorating cash position.

First Marblehead (FMD) sliding over $5 on a downgrade from Sandler O'Neal (ph). The analyst concerned the company may be - the bank may be forced to suspend its dividend because of troubles in executing securitizations.

Bristol Myers Squibb (BMY) rising $0.20. The drug maker targeting $1.5 billion in cost savings from a restructuring which announced a 10 percent cut in the work force, widespread plant closings and shedding certain assets.

Electronic Data Systems (EDS) rising $1.49. They'll plan a $1 billion stock buyback and the chairman, Mike Jordan, will step down. It'll be taken over by the CEO Ron Rittenmeyer (ph).

Shares of Guess (GES) going up $2.30 in reaction to a 33 percent jump in third quarter profits. Results were $0.04 above estimates.

And then Blyth (BTH), this is a candle making firm, up more than $4, an impressive turnaround there as third quarter profits came in $0.17 a share, versus a loss in the year ago period.

On the NASDAQ, Apple (AAPL) rising $5.69.

More profit taking in Research in Motion (RIMM), down a little over half a dollar.

Google (GOOG) gaining more than $14.

Microsoft (MSFT) gaining $1.38.

Comcast "A" (CMCSA) down over $2.50. The cable provider seeing lower subscriber growth about a half a million fewer new subscribers than previous forecast.

Intel (INTC) up nearly $1.

Cisco Systems (CSCO) up more than half a dollar.

Baidu.com (BIDU) up another $4.45.

Oracle (ORCL) up $1.19.

First Solar (FSLR) rebounding more than $11 after yesterday's $14 loss.

And then Nvidia (NVDA) up $1.66. The company leaked the specs on its new graphics card which aren't supposed to be released until December 11th.

And finally, InterDigital (IDCC) surging $3.13. The company says it won a $134 million arbitration award against Samsung on a patent infringement case.

SEARCH FOR RELATED TOPICS

Click on a keyword below to browse related content.